Putnam Investments’s Putnam BioRevolution ETF SYNB Stock Holding History

Putnam Investments’s Portfolio SYNB Stock Details SYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$3.64M	Hold	125,000	–	–	﹤0.01%	526
2023 Q3	$3.34M	Hold	125,000	–	–	0.01%	550
2023 Q2	$3.47M	Hold	125,000	–	–	0.01%	565
2023 Q1	$3.41M	Hold	125,000	–	–	0.01%	552
2022 Q4	$3.25M	Hold	125,000	–	–	0.01%	625
2022 Q3	$3.1M	Buy	+125,000	New	+$3.1M	0.01%	605

Other funds holding SYNB

Glenview Trust Louisville, Kentucky $6.37B AUM 23.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Putnam Investments's SYNB Position: Q4 2023 in Review

Putnam Investments held its Putnam BioRevolution ETF (SYNB) position steady in Q4 2023 at 125,000 shares worth $3.64M. The position accounts for ﹤0.01% of the portfolio, ranked #526.

Putnam Investments first reported a position in SYNB in Q3 2022 and has held it in 6 quarters since. 5 funds tracked by Wall St. Rank hold SYNB as of Q4 2023.

Putnam Investments held 125,000 shares of Putnam BioRevolution ETF worth $3.64M as of Q4 2023.
Putnam Investments left its Putnam BioRevolution ETF share count unchanged in Q4 2023.
Putnam BioRevolution ETF made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #526 holding.
Putnam Investments first reported a position in Putnam BioRevolution ETF in Q3 2022 and has held it in 6 quarters since.
5 funds tracked by Wall St. Rank held Putnam BioRevolution ETF as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.